Bill Kapp is a former orthopaedic surgeon who built nine hospitals, founded Fountain Life alongside Peter Diamandis and Tony Robbins, voted the number one longevity centre in the world by the Buck Institute. He started Fountain Life because of one devastating realisation: the American healthcare system is designed to treat disease, not prevent it. And by the time most people find out they are sick, it is already too late. In this conversation, Bill reveals why 88% of Fountain Life members who consider themselves healthy already show signs of cardiac disease, why the United States spends $5.3 trillion on healthcare and still ranks 64th in longevity, and what his mother's death from stage four ovarian cancer taught him about the cost of waiting for symptoms. He also explains why early detection could lower healthcare costs by 70%, why GLP-1 drugs are the first true longevity medication, and the two things he says will do more for your long-term health than almost anything else. He explains: ◼ How Fountain Life collects 240GB of data about your body and turns it into an action plan in under five minutes using AI ◼ Why 60% of US bankruptcies are caused by medical debt and how preventive care fixes that ◼ The 12 hallmarks of ageing and which ones you can actually change right now ◼ Why GLP-1 drugs like Ozempic may be the first true class of longevity medication ◼ Why women should be on hormone replacement for life, not just ten years ◼ The two daily habits that protect your long-term health more than anything else: muscle mass and sleep You can follow Bill and Fountain Life here: ◼ Website: https://www.fountainlife.com ◼ Instagram: https://www.instagram.com/fountainlife **This content is for informational purposes only and should not be considered medical advice. Always consult with a qualified healthcare professional before making any health or lifestyle changes.**
Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.
Transcript
From the show. Tap a time to play from there.
SPEAKER_00Everybody makes money in the US health system the sicker you are. But the United States spent$5.3 trillion on healthcare. And yet we rank number 64 in longevity. The reason we started Found was due to my frustration with the current US healthcare system. Today in the United States, 60% of people who go through bankruptcy go through bankruptcy because of medical debt. And the reality is it doesn't have to be that expensive. And it is only expensive because we chase disease. 88% of our members have some form of cardiac disease.
SPEAKER_0188%.
SPEAKER_0088%. Because I just recently had a patient that came in and their physician said they would not order the test unless they were symptomatic. And my problem with that is they're setting him up for a possible heart attack.
SPEAKER_02When do you think AI will know our health better than ourselves?
SPEAKER_00I think that's now. We've been training an AI called ZORI, which is our in-house AI that we've been training for the last three years with uh reinforcement training with our physicians and using special algorithms. Uh and it is very clear that Zori, while um uh can ingest more data than our physicians can, can process it faster and can find associations in the data faster than our physicians can. What it happens is that we always say it's almost like having an autopilot. It allows the pilot to fly the airplane better and then they can make small adjustments.
SPEAKER_00And this is what Zori does for our clinicians. So when we absorb 240 gigabytes of data, everything from your whole genome sequence with all 25,000 of your genes, on top of all of your imaging and all of your uh microbiome analysis, all your blood biomarkers, your wearables, your sleep, your medical history, uh your toxin counts, uh, your uh uh any of your uh other measurements that we do, all this 20 plus test that we do, uh, it'll let Zoe can analyze all of that and then make sense of it and put it into an action plan within two to five minutes.
SPEAKER_02That is impressive. I have to say, I've been one of the lucky person seeing the beta version of Zoe at the very beginning. And also like what's amazing about this AI system is actually captured all my blood tests, and then I could just give him or her a question. Right. And then they can give me some very interesting answers. It's better than you know, way other AI models.
SPEAKER_00And I think the other, the other uh advantage that we have. So so when you look at most of the base model, large language models, the frontier models, whether that be Claude, and they're very good, don't get me wrong. Uh, whether it be Claude, OpenAI, even Gemini, they're very good, but they're only accurate to about a 70% level. And then what you're gonna do, and so that the goal with Zori is to make Zori the ultimate longevity AI that is actually vertically trained in the field of longevity, which is different than vertically training an AI on sick care medicine, if you will, or hospital-based records.
SPEAKER_00So, what we are very fortunate is that because we have over 10,000 people that are do our testing process and they're fully quantified, we have a very deep repository of data to be able to harness. Plus, we have all of the treatments we've been doing for people for multiple years. So we can see what's works and what doesn't work in terms of whether we're going to reverse your brain age or reversing your cardiac disease. And we can see it now in the data. So even our clinicians who might have certain practice patterns are able now to learn from the data because they can see what worked and what didn't work, even if it might not have been their patient.
SPEAKER_00It might be somebody else inside the organization. We see this. So I think um, and I think where we're headed with Zori, and I think, you know, your early days on beta, uh, you're gonna find as Zori matures in the next six months that it's going to get even better because we're really making a pivot now to being able to, because since we do the full stack testing, we can now populate your hallmarks at aging. And so now for the first time, we can show you, even though outwardly you look very healthy, how are you actually aging, not just to epigenetic clocks, but how is your immune, you know, your cellular senescence looking, how is your dysbiosis looking?
SPEAKER_00How are the other the 12 hallmarks of aging? How are you progressing on those? Because those are really the core of what we do. So being able to draw the associations between the hallmarks of aging and your pre-disease status is really the key. And I think that as we move this forward, I think it's going to be very interesting because Zori can now tell you on your 12 hallmarks of aging where you rank. You know, so this are things that are very common. So you know, I used to people, you know, the 12 hallmarks of aging are great, uh, but what do you do about them? And so it turns out that the one uh that uh the one intervention that hits every hallmark is exercise.
SPEAKER_00Okay. And then the second one is sleep, and the third one is diet, right? So no big surprises there. However, then the question is what do you do next? So when we look at uh your SNPs or your genetic, you know, uh material, we can then determine are you a hypomethylator? Are there things in your diet or there are things that we're picking up in your microbiome that can tell us that you're dealing with leaky gut, that can tell us that what else you're doing? And then how do you fix the problem? And so it only not only becomes a great uh uh rubric for the the member to be able to see kind of where their health is progressing, but it actually becomes the standard on how we train physicians in the future.
SPEAKER_00Because we we have 20 very talented longevity physicians that we've been training over the years. Uh, but if we want to make this movement bigger, we need to be able to take regular physicians and train them. And so this is kind of where Zori becomes a co-pilot to train physicians as well.
SPEAKER_02You know, you are one of the original founder of the Fountain Life, and now you're the CEO of the company alongside other two founders is Peter De Amondis and Tony Rubins. You know, as an entrepreneur, as a physician, what's our golden nugget? What is our X factor?
SPEAKER_00I think where my business side of the house is because I had built nine hospitals and I had also built surgery centers and imaging centers and electronic health record companies. I'd run self-insured, you know, uh had our company had over 1,200 people in it at one point. You know, I know how to build and how to scale. And then, you know, how do you build on top of that? Now, the difference in longevity, uh, you know, when we started this endeavor five and a half, six years ago, nobody's talking about longevity five and a half, six years ago, right? I mean, it seems like a really long distance uh to be able to travel in a very short period of time.
SPEAKER_00Now everybody's talking about longevity. And so the what our focus has always been is not just to create a longevity platform, but ultimately make an impact on how we do healthcare. Because we know that if we can move healthcare from reactive and episodic to proactive and continuous, giving members agency over their own data for the first time, then we can really make a health impact across the world. And so, you know, our long-term goal for Fountain Life is to actually build the largest longevity platform in the world and have it able to, you know, have Fountain Life uh locations or our infrastructure in place at clinics around the world.
SPEAKER_00And so um, to do that, uh, we will be embarking on a franchise model, which we haven't done to until today. And so we have first locations coming up uh throughout uh GCC and also into Europe and then areas in South America. And so we think these this will be allow us to accelerate the data capture, which is so critical because when we start to look at training a longevity model, you want to train a longevity model on people who are not symptomatic with chronic disease. Because by the time you're symptomatic with chronic disease, the early uh um signals inside the data are already confounded.
SPEAKER_00So that's why hospital data doesn't work for this. And so when we look at the longevity movement, everybody has been using disease, chronic disease as a proxy and trying to intersect one or more disease proxies because they assume uh, you know, that um all chronic disease is age related when there's a certain component of that. But the question becomes, and so they say, well, we'll focus on heart disease or brain disease as a proxy for longevity. And I think that that may work, but I also think that one of the challenges is they're not assaying or not measuring all of the systems in the body.
SPEAKER_00And so when you're looking at an intervention, you really need to look at the all of the systems in the body and then measure your intervention, not just looking at cardiac, you know, interventions and then determining plaque, because we know that whatever the intervention is that's reducing heart plaque is probably having benefits elsewhere in the body, but we don't measure it in traditional FDA terms. So our goal is to be able to create not only this the largest database, but also create a testing platform that people can bring their gyrotherapeutics to fully quantified individuals, and then we can test pre and post and see what the intervention does, because that's would have been the biggest challenge.
SPEAKER_00And so to that extent, we already have a partnership with immunis, and we're testing their product inside of our ecosystem. We have a partnership with cellularity where we're testing their stem cells now for the first time, but we're able to collect data around the 12 hallmarks of aging in addition to looking at disease markers.
SPEAKER_02Why do my due diligence on your past and on your vision? I this reminds me of why look at the, you know, watch a movie of Matrix. There are people who live in the matrix and there has an architect behind the matrix. It seems like you are the architect for the future of the longevity. So, how you starting the Fountain Life, where does that come from?
SPEAKER_00So, first of all, uh a lot of credit to my co-founders, uh, and particularly Peter Diamandis and button and Tony. I mean, I go back and I tease Tony, but you know, I have his tapes from 1990, you know. So, so I have all of his VCR tapes from 1990. And uh, and so he was a formative influence early in my life. But more importantly, Peter, who I have followed his career for 20 to 30 years because he's such a visionary and being able to articulate what the vision for the future is. Uh so Peter does a very job at articulating the what could be, and uh, and then, you know, and then Tony uh articulates a great vision for what people can be, you know, what the future can be, what people can be.
SPEAKER_00And then my job is to try to take those visions and uh and uh create concrete, you know, uh receptacles for that where we can then deliver on that mission. And I think, you know, what we what you know, my first my reason we started Fountain and what we started, even the predecessor of Fountain was due to my frustration with the current US healthcare system. Not that I haven't, you know, I was a very successful uh orthopedic surgeon. I had built lots of different venues inside of orthopedics, uh, and including hospitals. And what what my challenge was though, is we weren't solving the root cause of any of the disease processes which we were managing.
SPEAKER_00And I also knew that if we didn't find a way to do first principles thinking, meaning how do we start the I mean, so I always tell people, if you were going to build a healthcare system today from ground zero, and somebody just put you on earth and gave you unlimited resources, what would you build? Well, would you build what we have now, which waits for you to get symptoms? And we know that 80 to 90 percent of what we treat is chronic disease and it doesn't become symptomatic till it's late stage, and then it's harder to treat, or would you design a system kind of like the airline industry does, where they do preventive maintenance and system checks and uh and uh part replacement and everything else uh so that there are never any problems?
SPEAKER_00You know, would you try to avoid the problem downstream, or would you try and detect problems early, uh, like the airline industry, or would you do what we have now? And so I think our system has evolved because we basically um the premise of medicine is symptom-based medicine, meaning we don't start to the treatment of you until you manifest symptoms. Because our idea is as long as you're asymptomatic, you're obviously healthy. And we know that's absolutely not true in the vast in at least 14% of people have something very serious that they would mean if I'm feeling perfectly healthy today, I could have disease that I don't know.
SPEAKER_00Absolutely.
SPEAKER_02Could you expand that concept?
SPEAKER_00Yeah, so so I will tell you our average age is 52 in the company today, in terms of our members. Um, we have done over 6,000 advanced cardiac scans on people today. And I will tell you that even though so we have about 60% women, or sorry, say about 55% men, 45% women, average age 52, 88% of our members have some form of cardiac disease.
SPEAKER_0288%.
SPEAKER_0088%.
SPEAKER_02And the those I imagine the people want to get themselves tested. They're already very proactive towards their house.
SPEAKER_00And they those are the ones that come to us, but the regular medical system won't is not going to test you unless you're high risk, according to family history or your blood biomarkers, or you already have symptoms. And you don't get symptoms with heart disease until you have a major blockage in your heart already. So 70, 80% blockage, you might get some symptoms. And our goal is to find the people that have a little bit of disease and show them how to reverse it. So when we look at our 6,000 people that have been through our testing, just looking at advanced cardiac scans, we know that 14, almost 15% of them have moderate or severe heart disease and don't know it because they're totally asymptomatic, right?
SPEAKER_00So it's so uh a really good example recently. Uh I was uh speaking recently at a country club, and a woman came up to me and she said, uh, I'm angry with you. And I said, Why? She says, Because your testing told me I wasn't as healthy as I thought I was. And I said, Well, what do you mean? She goes, Well, my husband dragged me to your testing and I told him, I am not unhealthy. I have been, I am in, I'm 65 years old. I have never drank alcohol, I'm on a plant-based diet, I exercise every day, I have no symptoms. Uh, everybody in my family is sick, but not me.
SPEAKER_00And you found a 95% blockage in one of the main arteries of my heart. So this is the problem. The problem is we don't look unless you have symptoms. We know half the people who uh have their first heart attack don't survive. And we've not done a very good job at detecting heart disease early when you can do something about it. We wait until symptoms appear. And I think this even is more important because I just recently had a patient that came in this past weekend, very prominent individual who uh needs a CCTA.
SPEAKER_00You know, they're very high in the government, and their physician said they would not order the test unless they were symptomatic. And my problem with that is they're setting him up for a possible heart attack. And he won't know it because his doctor had more influence over him than we did. We were just seeing him for the first time. So, so the point is that uh there are there's a lot. We know that uh in our members who all come in asymptomatic, uh, we find uh cancer in three to three and a half percent of people, we find aneurysms in three to three and a half percent of people, and in 14% of people, we find something that is potentially life-altering, meaning it could be an early stage cancer, it could be a uh an aneurysm, or it could be something like a significant blockage of the main artery of your heart.
SPEAKER_00So the point is you need to look because your body is very good at hiding disease. And you just don't, because we all know this. I mean, my mother unfortunately died of stage four ovarian cancer, right? Uh, when did we find out about when when she started having symptoms? Well, what were her symptoms? Well, her symptoms are very typical for stage four ovarian cancer, you know, abdominal bloating, abdominal distension, abdominal pain. But by the time that happens, the cancer spread throughout the body. Okay. The time to catch it is when it's very small and asymptomatic and in an ovary where we could have gone out, gone in and done a surgery.
SPEAKER_00It would have been an outpatient procedure, she would have been alive today. But instead, we spent, you know, a million dollars of treatment and she still died a very painful death. So the point is it's not just the isolated cancer patient, but we do not make an effort in the United States to spend money to find problems early so that they don't become late-stage problems. We just don't do it, unfortunately.
SPEAKER_02Yeah, if I recall correctly, last time I checked, it's 97% of budget is going to sick care. Only 3% is going to health care.
SPEAKER_00That's exactly right. And so I tell people, you know, uh in 20 uh 24, the United States spent$5.3 trillion on healthcare, just in the United States, for 4% of the world's population. The entire global spend on healthcare, including the United States, was 10.8 trillion. So we spent about one half of the entire world spend on healthcare, and yet we rank number 64 in longevity. So by anybody's measure, that's a terrible return on investment.
SPEAKER_00And the reality is it's not that we don't have the resources to test people at scale. We just don't have the will to do it because we would but because and and this may get me in trouble with my colleagues, but everybody makes money in the US health system the sicker you are. The m sicker you are, the more money they make. And unfortunately, there's nobody that is trying or is paid to keep you healthy.
SPEAKER_02That's why, you know, I feel what you guys do here in Fountain Life is incredibly important. Um, not only that you're testing the people who walk in the door, you're actually setting a new mansight in the society broadly that even the people who couldn't come here, they could at least be aware and then go get themselves tested elsewhere, right? So when we get ourselves test, let's say if we find some problem, what's we're going to do with it?
SPEAKER_00So it depends on what it is, right? So if it's something uh small, we can manage it here. But if it's a stage one cancer, we have pipelines to get you right into the best cancer specialist in here in Texas or uh in Florida, and to the go to the Mayo clinic, we can get you treated really cool, really quickly for our members. Uh outside of that, uh, you know, if it's cardiac, if it's severe and it's something significant, we'll get you right into a cardiac specialist. Because, like in, for instance, if that woman has a 95% blockage, she's gonna have to have a procedure for a stint so that that blockage doesn't go totally block over, right?
SPEAKER_00And I think that we just need to be able to get people there. So we are going to find things, but you know, the long-term hope is not that we just find disease early and do intervene early, but the long-term hope is how do we start looking at your hallmarks of aging and the underlying reasons for all of these processes to put you on a path so that maybe you may never get those late stage. And also, what are the newest interventions that are coming to even reverse some of the disease processes that we're have very little success so far? I think it is very clear, though, uh, that we can do a very good job today uh at detecting heart disease early, cancer early.
SPEAKER_00Uh, we believe 90% of people, by the way, we think should never have a heart attack. There's no reason with the technology we have and the way the technology can be done. As a matter of fact, the scanner that we use here is the latest state-of-the-art scanner. And you can have your entire cardiac uh, you know, architecture and all your vessels uh uh analyzed in 10 minutes.
SPEAKER_02Oh, that's that's amazing.
SPEAKER_00It's one single scan, it's the lowest radiation of any scanner in that's made today. And literally in 10 minutes, we can tell you what your heart looks like and whether or not you have plaque or don't have plaque, and whether it's significant, what's calcified, what's not. What's important about that is whether it be cancer, heart disease, neurodegenerative disease, or metabolic disease, all of those can be treated very effectively today. You can reverse diabetes today, as long as it's not type 1 diabetes, it's very easy to reverse.
SPEAKER_02Okay, how? Like that is very interesting.
SPEAKER_00Type 2 diabetes can be reversed. We do it routinely here.
SPEAKER_02Explain that.
SPEAKER_00Yeah, so it's a combination. Uh, some is pharmacologic, you know. We we are big believers in the GOP ones because the things like semi-glutide are very effective at improving your overall uh metabolic rate. But in addition to that, there's dietary interventions, there's correcting your gut function, which has a huge impact on all that, and then looking at overall inflammatory markers. So between a combination of diet, exercise, and pharmacologic interventions, uh, in our current population, the people who come to us, we reverse diabetes in over half of our members.
SPEAKER_02Or a how long period and what they have to do within less than two years. And do they have to change in their bad completely? And then can they get rid of, like, say, GLP1 or any group?
SPEAKER_00Some of them get off the GLP ones. We actually believe GLP1s are probably one of the new longevity drugs, but not at full dose, in microdose. And we think microdosing because we're seeing effects across the entire body. There's not a more effective drug at getting rid of your liver fat than GLP1s.
SPEAKER_02Okay, that's very interesting. Okay. And our channel called the Humanware Project. So we believe you have hardware, software, and then to be better over humanware. And actually, not every audience is come from a medical background or have a preventative healthcare mindset yet. So could you explain your very simple form? What is GLP1 and what it do for us? Or what's your opinion on it?
SPEAKER_00Yeah, so I actually think it's the first class of longevity drugs, and we will find different versions of these drugs as we move forward. Uh, the original GLP1 drugs were designed, uh, it means glucagon-like peptide one, which is actually a synthetic version of a peptide that your body normally produces. Peptides are very small proteins that can elicit different uh reactions inside your body. And in this case, this very small peptide, number one, works to control your appetite. Okay. It delos it slows down your stomach from emptying so you feel full after you eat a meal.
SPEAKER_00But more importantly, it sends a signal to your liver to make more insulin. And that by itself helps drive your blood sugar down. Okay. So that's where we see it on the at the high level. But we also know that that little peptide also works on your mitochondria and it stimulates mitochondrial function. And so this is why we're starting to see even uh things like Parkinson's disease get better with GOP1s. We're seeing uh cancer rates. It looks large cohort studies, looks like there's a lower cancer rate.
SPEAKER_00And we're seeing things like uh uh like dementia, particularly Alzheimer's disease. We think there's going to be a positive impact on that. There are a lot of people that believe Alzheimer's disease, because of its neuroinflammation, is really type three diabetes of the brain. And so there's a lot of theories around this. Not everything is all neuroinflammation, not everything is amyloid. I would tell you that I feel like we're just starting to scratch the surface looking at the body, but we have to look at the body in totality. Looking at just one organ is what got us in trouble because you know the brain doctors are only just in the brain.
SPEAKER_00They're not just in the heart. And the heart doctors don't care about the brain. They just care about the heart. The problem is we don't have a quarterback anymore. You need somebody that looks at the whole picture. And so that's what we hope to do with fountain being able to look at at fountain light being able to look at all of the different systems in the body and how they interact with each other, especially as we start looking at things like these GLP ones, which we think are going to be really remarkable.
SPEAKER_02When it's come to the healthcare, it can feel very, very overwhelming. And it's really nice you talk about that 12 hallmarks of longevity. So could you take us dive into those 12 hallmarks?
SPEAKER_00One is genetic instability or genomic instability. And obviously the most common manifestation of that is cancer, right? But we can also measure how rapidly your DNA is being oxidized or degraded. We can measure that in your urine now. So we can start to see kind of where your DNA is. We'll look at your telomere length, which are the end caps on your chromosomes, and that certainly has some impact. We'll look at epigenetic changes and epigenetic regulation. We'll look at nutrient sensing. There are areas like there is stem cell exhaustion.
SPEAKER_00There are areas looking at mitochondrial function, and then there's like four others. But all of these, some are easily modifiable and some are not. Okay. Some are like more etched in stone like genetics. However, uh, we believe that genes load the gun, but it's really environment that pulls the trigger. And so when we start looking at the interventions, it turns out you can improve your mitochondrial function, you can get rid of senescent cells, you can improve uh your overall uh, you know, your uh stem cell exhaustion issues, you know, using regenerative therapies.
SPEAKER_00So there are lots of interventions you can do with different levels of evidence backing all of those. But what's more important is that even people who look really on the outside really healthy, and even if they put them through our screening and we don't see any overt disease going on, and we'll the normal doctor would say, oh, you're fine. When we measure their hallmarks, they're not as healthy as they could be.
SPEAKER_02Okay. So after we find the our mark and our current mark, we can close the gap, basically.
SPEAKER_00That's correct.
SPEAKER_02Uh that that was very actually good to learn because I do see the difference with people who take good care of themselves versus the person they don't. But what are the most important tests we need to get like now?
SPEAKER_00Yeah, I tell you if if there's anything that everybody needs to get right now, uh, I would tell you um certainly uh easy things to do, obviously, or complete blood panel, you know, that's super important. But outside of that, I actually think getting a CCTA, an advanced cardiac scan with AI read for anybody over 40 is critical because you need a baseline. You want to know that. Uh, for men and women, if you're relatively young, you need a hormone profile because you need to know exactly what your estrogen, your testosterone, all of that is, whether you're male or female, and what your normal healthy ranges look like.
SPEAKER_00Because if you're 25 years old, you would love to know when you're a peak physical condition what your testosterone is as a male. Because when you become 60 and 70, you probably need to be put back there. And we don't know what your normal range is, and everybody's a little different. So I think that's super important. But I think the advanced cardiac scan is something we'd highly recommend. We think a very easy thing to do is a DEXA scan. If you can't get access to a full-body MRI, do a DEXA scan, it'll do body composition, muscle mass. Uh, and then I always tell people that there's nothing else you do if you don't learn anything else from what we're talking about.
SPEAKER_00Get your muscle mass up. Muscle mass is the biggest thing you can do to protect your long-term longevity. Uh, people with the highest muscle mass have the lowest disease. People with the highest muscle mass have the least incidence of cancer, and people with the highest muscle mass live the longest.
SPEAKER_02Right now, a lot of uh female leaders, like they are like a part of them they take care of their job and then also take off their family. And then when they are cheating the peak moment for their career, very likely they will be arriving to the time of the menopause. Correct. So, what is there anything we can do to basic and make that transaction very easily? And how we can learn more about what we can do for ourselves.
SPEAKER_00No, so it's a great question. So women's health is a big issue and it's getting more of an issue because historically, you know, males see their testosterone drop gradually over time. And so we generally don't treat males for testosterone replacement until recently because uh they don't have acute symptoms. And so, because we're symptom-based in US healthcare, if they're not having symptoms, we're not going to treat them, right? Probably the wrong way to look at that, but I just will tell you. When we look at the 12 hallmarks of aging, though, hormones impact four or five of the major hallmarks.
SPEAKER_00So for women, particularly, and particularly women uh members at Fountain Life, we are very, very serious about hormone replacement for women, not only in the menopausal, but also pre-menopausal. Because what we want you to do is maintain healthy hormone levels throughout your life. Now, as long as you have no contraindications, and and we uh font, we screen you for all of that here at Fountain Life, uh, our female members and our physicians will keep women on hormones their entire life.
SPEAKER_02Oh, incarnate.
SPEAKER_00Not just 10 years, but their entire life. The reason mainstream medicine says only 10 years is because that's all the data they have. They have no data beyond that. But the reality is if it is that good for your cellular health, and by the way, you know, hormones are great for uh, you know, they're certainly great for sexual drive, they're certainly great for a lot of things, but for women, they're particularly great for cognitive health and bone mass. So as an orthopedic surgeon, I could tell you without estrogen in your body, you're not going to build bone. You have to have estrogen to get the calcium to go into the bone.
SPEAKER_00So for women, uh, particularly, and you you could see this with women. And in a matter of fact, the FDA just recently, I don't know if you saw this, but Dr. Matter McMarty McCary just came out and said he apologized to women for the last 25 years for the misinformation that has been given around hormone replacement in women, and that all of these women should have been on a hormone replacement to begin with, because the study that said you shouldn't take it was a flawed study.
SPEAKER_01Oh.
SPEAKER_00And so he's now recanted entirely. And now there are just large swaths of women out there that are going on hormone replacement as long as they don't have a contraindication. And so uh, if you talk to some of our women physicians, uh particularly one of ours, uh, she will tell me, I said, you know, how do you know what's normal? She goes, Well, when my 90-year-old uh females can think as clearly as they did when they're 25, that's when I think I win.
SPEAKER_02What is the age women should start to consider about learning about their hormones?
SPEAKER_00So I think anyone, so obviously, because of environmental factors, women are going through menopause early now. And a lot of them are having changed this quote, change of life is like people used to call it earlier than ever before. So this is one of those things that I think annually women need to look at their hormone levels. They have to look at in respect to what their ovulation cycles and things of that nature are. But they do need to monitor it. And when it starts to drop, you know, and when your fertility days are over, then you need to be seriously thinking about it prior to having hot flashes and all the side effects from menopause.
SPEAKER_00And I think that uh women need to seriously think about that because certainly uh keeping estrogen up means skin tone stays better, your skin elastin stays better, less wrinkles, uh, less muscle mass loss, less bone loss, better cognitive function. And that why that's why you see women who've been on hormone replacement, they're perfectly erect, they're not hunched over.
SPEAKER_02It seems like uh you need to be on certain drugs every, you know, every day. And uh is that means that it's very costable, or is that covered by the government?
SPEAKER_00Well, the government will cover this now because it doesn't buy off on this necessarily, except for maybe the first 10 years, if you find an advanced physician. But it the drugs are very inexpensive. And these are these are creams that women take. It's estrogen and progesterone, and they just it's usually through a compounding pharmacy and they just apply it to their uh the inside of their thighs or you know, sometimes under their arms. It's very easy, and it's just a cream, very inexpensive. I would say less than probably certainly less than a hundred dollars a month. So these these drugs like testosterone and estrogen, they're just extremely inexpensive.
SPEAKER_00And the main reason they're inexpensive is because you because you can't patent them. And so, since they can't be patented, nobody's tried to make a lot of money off selling testosterone, and that's one of the reasons we don't have great studies around them either, because nobody can make a dollar off of you know repackaging it and patenting the and trying to sell it.
SPEAKER_02Yeah, I think what's very fascinating because many of my friends is Fountain Life's members, and they all told me, like, we share notes on what we do, and they said, Oh, um, we have do a new stem cell treatment and this and that. So, can you uh take us into the universe of the Fountain Life? What are the new treatments sometimes you're sending your members to?
SPEAKER_00Yeah, so um most of the treatments we do now we do inside of Fountain Life. We used to send people out for stem cell therapy outside the United States, uh, but now we can do it legally in the state of Florida. Now, it is not FDA approved, but the FDA does not in those states necessarily have jurisdiction. So one of the things we're doing, though, is we're not just treating people with stem cells and when we're screening them very carefully, but they're all enrolled in a study. Because what we want to do is study the effects of the stem cells uh before and after, and then also be able to track people's progress.
SPEAKER_00And so uh now in the state of Florida, uh, we have two locations, one in Orlando and one in Naples, Florida, where people can come in, go through the screening process because we want to make sure you don't have a cancer or something else that's going on, and then you can receive stem cell therapy. And so these are stem cell therapy uh through Dr. Bob Herri's company, Cellularity, and they are literally probably the number one stem cell company in the world that has the best studied stem cells of anywhere around in terms of they've been in FDA trials already. We know what the safety of the stem cells are, they're derived from the placenta.
SPEAKER_00Uh, they are we we know all of the factors around them. They're the safest uh stem cell population you can find, and they've been in clinical studies. So those are the ones that we use. Uh other things we can do is using things around um treatments uh using some of the new uh regenerative medicines called orthobiologics that are derived from amniotic fluid. They have huge capability of regenerating tendons and also helping with osteoarthritis. And then the last thing that we're doing right now very aggressively is uh we're looking at therapeutic or we do therapeutic plasma exchange, which is where we can kind of clean out all your blood, bad blood plasma, give you back some albumin, and that actually lowers your physiologic age pretty significantly.
SPEAKER_00Our long-term goal, though, is actually moving into executive health. So people who have companies and they have five or more individuals and they want to come through the same testing, that core testing, they can do that for about$6,500. So all of this continues to scale down. And then uh for our executive health clients this year, we will also launch our base program. And that's going to be a$500 program where people can get their advanced blood biomarkers done, upload all their medical records to Zori, all their wearable data, all their past medical history, all of that. And then Zori can start to give you advice on your health.
SPEAKER_00Where our long-term goal, though, is as we move forward into the franchise models is going around the world, uh, we will be bringing our dead digital technology stack to the franchise model. And we know that different locales will have different price points. We also think that over time, uh, the cost of the technology continues to drop. And as our volumes continue to grow rise, then our goal long term is hopefully be able to bring the overall price down. And then it also depends on when, you know, what the cost is in terms of, you know, how how less expensive the machines get, uh, how uh less expensive the AI programs get over time for doing some of this advanced analytics.
SPEAKER_00And we're already seeing the price of whole genome sequencing drop. We're also seeing the price of uh microbiome analysis drop. Also, the AI protocols are drop, the price for those is dropping, some of those that we utilize on top. So I think that's one of our long-term goals. But then our AI goal is to be able to take this massive amount of data that we've collected and then find algorithms in the data that could be applied not to a full testing stack in the future, but maybe a small testing stack. So maybe in the future, because of the deep learning we can do with the AI, instead of having to do 20 tests, we find that we can get 95% of the same outcome from maybe blood tests and maybe a cognitive test and maybe a strength test that could be widely scaled around the world.
SPEAKER_02And what makes function life's tests special like compared with other like medical centers?
SPEAKER_00So uh most medical centers will not do whole body and brain MRI. Okay. We've been doing that for over five years. Uh, most medical centers will not do um ACCTAs on asymptomatic people, okay, once again. And then I think beyond that, there are therapeutics that we bring into Fountain Life that probably you're not going to find anywhere else. So, for instance, if you want the latest cutting edge therapeutic to reverse your cardiac plaque, you're probably gonna find it inside Fountain Life that's in an FDA trial. Uh, if you're looking for the latest, uh, you know, our job at Fountain Life is to scour the world for the latest treatments that are cutting edge that our members want.
SPEAKER_00And so as we move forward, the real value of what we're doing is really going to be built into the data because the data is where all the opportunity will lie and also will be the area where we find the patterns that can help us long term.
SPEAKER_02What is the story of when do you start to shifting your mindset from the traditional healthcare into this new mindset, let's say? And what is the story that touched you personally to make you get on this journey?
SPEAKER_00Yeah, so I think uh two things. One is uh exposure to people like Peter, uh Diamandis, and Daniel Kraft, who had been talking about this for they've been talking about this for 10 or 12 years, this idea of these are the new exponentials that are coming. And be Peter has been talking about exponential technologies for years. Uh, and what is interesting is is when you start to see it for the first time, your first uh in my first glance at it, uh it being very traditionally trained is that can't be that can't be true. I mean, there's no way that could possibly be true. That everything they're telling me about computers reading x-rays and and and AI doing this and then whole genome sequencing coming down to$100.
SPEAKER_00Uh and yet uh if if you follow these curve, you know, progressions of these technologies, you start to see it happen. So I think the first thing was getting exposed to that through Peter's uh ecosystem. But I think the biggest thing was um obviously my mother's condition, very frustrating, you know, uh to find that out late. Uh, you know, when I think that that's something that should have been picked up very, very easily if we just had the right technology at the right place. And I think the other thing is uh, you know, I'm very up, I got very upset when I started hearing patients of mine talking about how expensive healthcare was.
SPEAKER_00And so today in the United States, 60% of people who who uh go through bankruptcy go through bankruptcy because of medical debt.
SPEAKER_01Yeah.
SPEAKER_00And the reality is it doesn't have to be that expensive. And it is only expensive because we chase disease and we don't look for it early when it's cheap and easy to treat. And I think that was the frustration when I talk to people who and it's not the necessarily the fault of the hospital systems, but these large hospital systems that don't pay taxes uh are the ones that are driving these exorbitant costs up because the patients don't have the money. And it's not like people don't spend money. I mean, the average Burke family of four in the United States now spends$27,000 a year on health insurance between them and their employer.
SPEAKER_00So the idea if we can get the testing down to let's say$3,000, then that's a really good investment on the front end, right? And maybe that can be maybe it's$500 a month, maybe it's$300 a month. But the point is that this could become very accessible for people who want it. And it certainly could be employee, and I think the other real bug opportunity is with employers. So in the United States, 70% of all employees are covered by a company that pays for their insurance through self-insurance, which means the company bears the risk.
SPEAKER_00And most of those companies are unaware that if they were able to do this testing on their employees at scale, they could lower their costs dramatically because they would catch those events early that usually break the bank late. And so being able to catch these what we call black swan events, where somebody has um a cancer or an aneurysm or uh or a heart attack and didn't know it, you know, then when they can catch that early, it's super important. And so I think that's where the opportunity lies.
SPEAKER_02I super aligned that like with the extreme kind of monset, like catch it more servants very small, it's actually in the end lesser as a bill.
SPEAKER_00Much smaller. Yeah, much much smaller. We looked at a thousand people inside Fountain Life, and when we were catching disease early and paying for it, what it would cost, versus when it became symptomatic and you would treat it, uh, you could lower healthcare costs just in that 1,000-person cohort by 70%.
SPEAKER_0270%.
SPEAKER_0070%.
SPEAKER_02Yeah, I think everything is a decision to make today then.
SPEAKER_00That's correct.
SPEAKER_02Yeah. And they're like, uh actually thinking from entrepreneur to entrepreneur, very amazed by when people have a big vision and they really want to use their talent for good. But when you go down to everyday business practice, you know, people only see the amazing side that you are opening a new center here. But we would actually like to understand what is your like entrepreneurship kind of tips for us so that when we think it's very hard into a day-to-day practice, we can think on that.
SPEAKER_00No, look, I mean, I think that it's a great question. I so I would tell you, you know, vision is really easy, but execution is really hard. And I think with people who underestimate how hard execution is. So I would tell you, uh, number one, uh, you need to be committed in your vision uh and you need to reinforce that by surrounding yourself with people who have shared your same vision. Uh everybody we hire into Fountain Life, we hire to mission. Uh, and we don't hire uh if I always tell people, you know, if you're not really interested in a 996 protocol and you're really not interested in helping us change the world, uh, that this probably isn't for you, okay, because it's it won't be easy, but it will be very highly rewarding.
SPEAKER_00Uh the second thing is is find really great talent. You should surround yourself with people better than you are. And and generally speaking, you know, the best people kind of work for somebody else's company, right? So you want to hire uh people to the mission and be able to attract those types of people. I think the other thing is maintaining a very flat organization and then having KPIs very uh um enumerated for every single employee, you know, particularly at your at your leads, uh, and then they'll know. And but my point is I want you to experiment.
SPEAKER_00I want you to fail occasionally, and I want you to fail fast, fail forward, fail often. But what I want you to do is get up and do it again. So you have to find people who are mission-driven and people who want to work hard. And then I think hard work and vision uh will get you 90% of the way there. And then timing is probably the thing you really cannot judge. Because timing, I think, still is probably in an exponential world one of the most important things that can happen to you. And you know, when we started this Fountain Life adventure five and a half years ago, I don't know that any of us knew that the longevity movement was coming.
SPEAKER_00You know, we couldn't see it, it wasn't around the corner, we had no idea. We probably could have gotten some signals after COVID, though, because COVID was the wake-up call for the world, because COVID exposed the fact that we don't do preventive care very well, that our populations are not particularly healthy, particularly here in the United States. And I think COVID called into question a lot of traditional dogma inside of traditional medicine, to where people today don't quite believe traditional medicine as much. So I think we're that's the opportunity. And then obviously the timing on, you know, being able to take advantage of generative AI, some of the new advances coming.
SPEAKER_00Uh, the, you know, the challenges in any type of exponential world is you need to really be tuned in on where the where the future's going and being able to see that and surround yourself with people like Peter and Tony, who kind of can see the future a little bit for you uh and can kind of help you stay out of maybe some harm's way.
SPEAKER_02What is your method to remind your team about the KPI? Because you have so many centers all around the world and you know, managing so many times, and then how did you communicate?
SPEAKER_00Yeah, so we have a once a week um a meeting, uh, all department heads and uh at every center. You know, I mean, this is at the corporate level, we have everybody, and everybody has their area, whether it be clinics or AI or operations, or uh we have uh sales, marketing, finance. Everybody has their specialty area. And uh we meet once a week, and then we all design and we everybody sets KPIs at the beginning of the quarter, and then we track them on a weekly basis. And then every week we meet, and then I'm available uh to any of the subject leaders, uh any of the subject heads, or I should any of our division leads, uh, I'm available to them anytime for a phone call.
SPEAKER_00I don't do one-on-ones during the week, okay, because I want them to run their shop and they don't need a lot of in they know what they need to do, they know what their rocks are, what their KPIs are. I'm always available. And if they need some help, I'm happy to do that. I think having flat organizations allows you to grow much faster. And I think it also helps because um people become empowered to do a much better job when they don't have to worry about too many layers of bureaucracy over them. So that's worked very well at up until now. I think um as we move forward, uh a lot of the AI tools have been tremendously helpful across and we use them all across our organization.
SPEAKER_02And those KPIs are setting by you or by the leaders of the region?
SPEAKER_00So uh I I outlined the general goals about what we want to do. Uh, we know what our sales targets are, we know what our uh booking targets are, we know what our membership renewal targets are, and then I leave it up to them to decide unless they get stuck. If they get stuck, then we sit down and we talk about you know, what do you need to do next? And what is it and and lot, not everything. I tell people, you know, sometimes companies are a little like an aircraft carrier. It doesn't turn fast, but you have its opportunity to do little tiny speed boats and go out and try new things. And don't be afraid to try new things.
SPEAKER_00But just don't do it for very long if it's failing. Okay. So what, you know, you know, um, you know, you you have to do something different, uh, and you cannot expect the constant same better results if you're not, you know, challenging yourself. And then, you know, what is different? I mean, I think what is different about what we do versus traditional medicine, we have to recruit or to, you know, find members that want to come to us. So we have to do a lot of education, a lot of outreach, a lot of marketing. Uh, traditional medicine just waits for you to show up when you're sick.
SPEAKER_00And also the customer service expectations are much higher.
SPEAKER_02Actually, one of the messages we wanted to send out through our channel is actually we believe success doesn't happen overnight. When people see, oh my God, you guys just lead this new movement, they were imagining it just a success overnight. But I've been seeing different stages of, you know, Fountain Lively open news centers. I understand how hard it must be. So, what are the most difficult moments around Fountain Live for you?
SPEAKER_00Uh, you know, I would say uh probably the most difficult things are making sure we understand what our members want and listen carefully and provide the outreach that they need. I think um, you know, the customer changes over time and we need to know who our customer is. And we also then uh the second component of that is hiring to physicians that really understand and are mission driven. I mean, that's always a part of it. Uh, I think the other thing is keeping the team motivated, you know, uh and promoting ultimate transparency throughout the organization is super important for me. Uh, but I would tell you, you know, this uh this endeavor for Fountain is really about uh going on about a seven-year journey since we kind of launched until you know, we weren't formally Fountain Life until about five and a half years ago.
SPEAKER_00But it's been about a seven-year journey. Uh I think it has taken an inordinate amount of time to identify the SOPs and the KPIs and the things that will move the needles in a business like this. Uh, because up until now, there's nobody we can copy. And so when you don't know who to copy, it makes it much, much more difficult. Um, you know, we were fortunate we were uh voted the number one longevity center in the world by the Buck Institute, by a member of our peers last December, which was quite an honor for us. Uh, but this field of longevity is relatively nascent. And there are a lot of people that think they're a longevity center, but they just don't know.
SPEAKER_00And so they hang out the name longevity, they do IV drips, they do this different stuff. They're not collecting data. And ultimately, for the longevity movement to be credentialed and successful, it has to have data and we have to have outcomes and to be able to prove what we do works. And so that's the challenge. Um, I think um, you know, balancing uh the PL between uh, you know, uh labor cost, supply cost, marketing, sales, and then what do we need to invest in? You know, how much more do we spend on tokens? How much more do we spend on AI support?
SPEAKER_00How much deeper do we uh, you know, develop our AI to stack? I mean, I think this is these are the things that keep us busy.
SPEAKER_02If one action, let's say if they take nothing from this episode, what is the one thing we can do to be better or health now?
SPEAKER_00Yeah, so I'll give you two because I think it's super important. Uh, number one is get your muscle mass up as high as you can. Okay. And however you need to do that, you know, if you're hormonally deficient, get on some hormones, find a way to get your hormones checked. Because a male who has insufficient testosterone cannot build muscle mass. Same thing for women. Women need to have their hormones checked, they need to build muscle mass. Women need to be in the gym. And the second thing is really sleep. Sleep is the most important thing that you can do that you have a lot of control over, but you need to get educated about sleep.
SPEAKER_00Uh, you know, uh, we uh uh, you know, Matt Walker has a great book called Why We Sleep, which is a great book to do. But whatever your sleep aids are, I mean, the simple, easy hacks are just cold rooms and and you know, and and dark rooms and all that. But there are lots of things you can learn around sleep hygiene because sleep is when your brain actually cleans itself, and that's the time that which you really want to do that. So I would say muscle and sleep are probably your two biggest hacks.
SPEAKER_02Oh, thank you, Belle. That's very helpful.
SPEAKER_00Good, happy to do it.
SPEAKER_02Thank you for watching this new episode of Humanware Project. So that we can bring out more amazing content like this one to you. Please like and subscribe. Your support means the world to us.
At 28, Richard Branson bought an island he couldn’t afford. Decades later, it is still his home, and the place where he lives by the principles that built the Virgin Group. In this episode, Méline returns to Necker...
As a young teenager, Randy Schekman cycled to his local police station and told the duty officer he was running away from home. His mother kept borrowing the money he was saving for a microscope. Half a century later,...
Most microscopes have a limit to what they can show us. Eric Betzig helped to break that limit, and won a Nobel Prize in the process. In this episode, Méline goes behind the scenes at Eric’s lab at UC Berkeley. Eric is...
Eric Betzig once walked away from science altogether. Years later, he and his best friend put $25,000 each of their own money into building a microscope on a living room floor, and it won him the Nobel Prize. In this...
What if some of the best health and longevity secrets are not found in laboratories or supplements, but growing on trees right in front of us? In this episode, Méline travels to Hainan, China’s tropical island, with her...